Related Experiment Video
Updated: Apr 12, 2026

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.8K
Presenting Numeric Information with Percentages and Descriptive Risk Labels: A Randomized Trial
Aleksandr Sinayev1, Ellen Peters1, Martin Tusler1
1Ohio State University, Columbus, OH (AS, EP, MT)
Summary
Presenting medication adverse effects (AEs) as percentages with risk labels significantly improves understanding and willingness to use drugs. This format is more effective than frequency or percentage alone for patient comprehension.
Area of Science:
- Health Communication
- Medical Decision Making
- Patient Education
Background:
- Previous studies show numeric adverse effect (AE) information enhances medication comprehension and use.
- The optimal numeric format for presenting AE likelihoods remained undetermined.
Purpose of the Study:
- To compare four numeric formats for presenting medication adverse effect likelihoods.
- To determine which format maximizes risk comprehension and willingness to use medication across different age and numeracy levels.
Main Methods:
- A cross-sectional internet survey with 368 participants was conducted.
- Respondents reviewed a hypothetical cholesterol medication with AEs presented in percentage, frequency, percentage + risk label, or frequency + risk label formats.
- Key outcomes measured were risk comprehension and willingness to use the medication.
Main Results:
- The percentage + risk label format yielded the highest comprehension (95%) and willingness to use (mean 3.3) compared to other formats.
- Comprehension differences between percentage and frequency formats were less pronounced in individuals with lower numeracy skills.
- The use of risk labels reduced the impact of age and numeracy on medication willingness.
Conclusions:
- Numeric adverse effect information presented as percentages with risk labels enhances medication risk comprehension and user willingness.
- This format is recommended for improving patient understanding and adherence to prescribed medications.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
565
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
565
Hazard Ratio
732
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
732
Relative Risk
2.6K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.6K
Randomized Experiments
9.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
9.3K
Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K

